MURRAY HILL, N.J. — Linde LLC has entered an agreement with Alliance Welding Supplies, Inc., creating one of the strongest gases supply options for life sciences customers in the San Francisco Bay Area. Under the agreement, Alliance, a Linde platinum distributor headquartered in Oakland, will supply gases produced by Linde to Bay Area members of […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it will collaborate with the University of Queensland Centre for Clinical Research in Brisbane, Australia, to increase understanding of the genomic differences between young and older patients with oral cancer and between progressive and non-progressive oral potentially malignant lesions. Oral cancer is part of […]
CAMBRIDGE, Mass. — LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences startups, officially began laboratory operations on November 15th. Key to its on-schedule opening was the generous support that the nonprofit organization received from its sponsors in the form of financial contributions, equipment donations, and in-kind services. In that regard, LabCentral […]
Munich, Germany — Genedata, a leading provider of advanced software solutions for industrial biotechnology, drug discovery, and life science research, today announced its collaboration with GOBI (“General Optimization of BIogasprocesses”), an interdisciplinary biogas research consortium consisting of leading academic and commercial members to improve the overall efficiency of biogas production. GOBI will be using Genedata […]
CHALFONT ST. GILES, UK –– GE Healthcare Life Sciences, (NYSE: GE) and Cellectis Group (Alternext: ALCLS), the global genome engineering specialist, announced today that GE Healthcare has licenced Cellectis to develop, manufacture and sell models derived from stem cells for use in drug discovery and toxicity screening. The agreement follows the announcement that GE Healthcare […]
LITTLE ROCK, AK – Vivione Biosciences Corporation (TSXV:VBI) today announced a new three-year Cooperative Research and Development Agreement (CRADA) with the Food and Drug Administration’s (FDA) National Center for Toxicological Research (NCTR). The focus of the CRADA is to expand the capability of Vivione’s RAPID-B™ diagnostic system. The Vivione RAPID-B™ system is a revolutionary high-performance […]
Louvain-la-Neuve, Belgium – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the closing of the sale of 100% of its Business Unit Cisbio Bioassays. Today’s closing has led to a payment to IBA of EUR 16.3 million. In addition, the contract includes […]
Paris and Codolet, France – The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in the field of products and services for human in vitro diagnostics and pharmaceutical research. Through this Management Buy-Out (MBO) operation Cisbio Bioassays becomes independent, with its […]
RUNCORN, UK – In efforts to ensure safe and healthy food, two leading European food testing laboratories are collaborating with Thermo Fisher Scientific at the company’s new Pesticide Analysis Center of Excellence to improve methods for detecting and measuring pesticide residues in food. The European Union Reference Laboratories (EURL) for Residues of Pesticides in Fruits […]
Anton Paar GmbH – manufacturer of high-precision instruments for the laboratory and production process, with its headquarters in Graz, Austria – has acquired CSM Instruments SA in Switzerland as of November 15. CSM Instruments SA will continue under the name “CSM Instruments SA | A company of Anton Paar” at the present location in Peseux […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
